Krsnaa Diagnostics Ltd — earnings calls

1 quarter summarised from transcripts filed with the exchange, every statement cited. Newest first.

Q1 FY27 — transcript filed; not yet summarisedQ4 FY26

Krsnaa Diagnostics reported FY26 revenue of approximately INR7,728 million with EBITDA margin of around 28% and reported PAT of approximately INR1,014 million, crossing INR1,000 million in PAT for the first time. Management said Q4 revenue grew about 4% year-on-year with EBITDA margin of 29%, while DSO improved from 155 days to 139 days during the quarter. Management outlined plans for Rajasthan ramp-up, retail scale-up, and further capital investment of INR5,000 million in FY27.